ibrutinib,zanubrutinib
beigene,janssen,abbvie
['lymsm', 'zanubrutinib', 'cll', ' ibru', 'alpine']
#ash22 lba | final analysis of alpine presented by jennifer brown . zanubrutinib shows superior orr &amp; pfs, and favourable safety profile compared with ibrutinib for r/r cll/sll. irc 2yr pfs 79.5% vs 67.3% overall, 77.6% vs 55.7% in pts with del(17p)/tp53mut #lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm